NO974255L - Preparation for once-daily injection month and useful as a depot contraceptive and in hormone replacement therapy for perimenopausal and premenopausal women - Google Patents
Preparation for once-daily injection month and useful as a depot contraceptive and in hormone replacement therapy for perimenopausal and premenopausal womenInfo
- Publication number
- NO974255L NO974255L NO974255A NO974255A NO974255L NO 974255 L NO974255 L NO 974255L NO 974255 A NO974255 A NO 974255A NO 974255 A NO974255 A NO 974255A NO 974255 L NO974255 L NO 974255L
- Authority
- NO
- Norway
- Prior art keywords
- once
- hormone replacement
- replacement therapy
- perimenopausal
- useful
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Reproductive Health (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Diabetes (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Det beskrives anvendelse av en enmånedssprøyte ("once-a-month- injectable") som inneholder en østrogen og gestagen komponent som aktive stof- fer for fremstilling av et legemiddel for å hindre befruktning og for sam- tidig hormonerstatningsterapi for kvin- ner omkring og før klimakteriet. Med dette legemiddel oppnås en sikker befruktningshindrende effekt med et "naturlig" østrogen (uten etyn- yløstradiol) med inngående, virksom terapi mot de begynnende østrogenbort- fallsfenomener så vel som en osteo- poroseprevensjon.It is disclosed the use of a once-a-month injectable containing an estrogenic and progestogen component as active substances for the manufacture of a drug to prevent conception and for concurrent hormone replacement therapy for women around and before menopause. With this drug, a safe contraceptive effect is achieved with a "natural" estrogen (without ethynyl estradiol) with incoming, effective therapy for the onset of estrogen loss as well as an osteoporosis prevention.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19510861A DE19510861A1 (en) | 1995-03-16 | 1995-03-16 | One-month injection as a depot contraceptive and for hormone replacement therapy for peri- and premenopausal women |
| PCT/EP1996/001201 WO1996028165A1 (en) | 1995-03-16 | 1996-03-15 | Once-a-month-injectable useful as depot contraceptive and in hormone replacement therapy for perimenopausal and premenopausal women |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO974255D0 NO974255D0 (en) | 1997-09-15 |
| NO974255L true NO974255L (en) | 1997-11-14 |
Family
ID=7757668
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO974255A NO974255L (en) | 1995-03-16 | 1997-09-15 | Preparation for once-daily injection month and useful as a depot contraceptive and in hormone replacement therapy for perimenopausal and premenopausal women |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0814811A1 (en) |
| JP (1) | JPH11501649A (en) |
| KR (1) | KR19980703058A (en) |
| AR (1) | AR002283A1 (en) |
| AU (1) | AU713258B2 (en) |
| CA (1) | CA2215382A1 (en) |
| CZ (1) | CZ289697A3 (en) |
| DE (1) | DE19510861A1 (en) |
| HU (1) | HUP9801691A3 (en) |
| IL (1) | IL117516A (en) |
| MX (1) | MX9707009A (en) |
| NO (1) | NO974255L (en) |
| NZ (1) | NZ304027A (en) |
| PL (1) | PL322202A1 (en) |
| SK (1) | SK123997A3 (en) |
| WO (1) | WO1996028165A1 (en) |
| ZA (1) | ZA962177B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0000313D0 (en) | 2000-01-10 | 2000-03-01 | Astrazeneca Uk Ltd | Formulation |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4826831A (en) * | 1983-08-05 | 1989-05-02 | Pre Jay Holdings Limited | Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens |
-
1995
- 1995-03-16 DE DE19510861A patent/DE19510861A1/en not_active Withdrawn
-
1996
- 1996-03-15 CA CA002215382A patent/CA2215382A1/en not_active Abandoned
- 1996-03-15 NZ NZ304027A patent/NZ304027A/en not_active IP Right Cessation
- 1996-03-15 JP JP8527295A patent/JPH11501649A/en not_active Ceased
- 1996-03-15 SK SK1239-97A patent/SK123997A3/en unknown
- 1996-03-15 HU HU9801691A patent/HUP9801691A3/en unknown
- 1996-03-15 KR KR1019970706467A patent/KR19980703058A/en not_active Application Discontinuation
- 1996-03-15 MX MX9707009A patent/MX9707009A/en not_active IP Right Cessation
- 1996-03-15 AR ARP960101766A patent/AR002283A1/en unknown
- 1996-03-15 EP EP96907506A patent/EP0814811A1/en not_active Withdrawn
- 1996-03-15 WO PCT/EP1996/001201 patent/WO1996028165A1/en not_active Application Discontinuation
- 1996-03-15 CZ CZ972896A patent/CZ289697A3/en unknown
- 1996-03-15 AU AU51108/96A patent/AU713258B2/en not_active Ceased
- 1996-03-15 PL PL96322202A patent/PL322202A1/en unknown
- 1996-03-17 IL IL11751696A patent/IL117516A/en not_active IP Right Cessation
- 1996-03-18 ZA ZA962177A patent/ZA962177B/en unknown
-
1997
- 1997-09-15 NO NO974255A patent/NO974255L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| SK123997A3 (en) | 1998-02-04 |
| ZA962177B (en) | 1996-07-29 |
| NZ304027A (en) | 2000-05-26 |
| PL322202A1 (en) | 1998-01-19 |
| DE19510861A1 (en) | 1996-09-19 |
| HUP9801691A2 (en) | 1998-11-30 |
| AR002283A1 (en) | 1998-03-11 |
| EP0814811A1 (en) | 1998-01-07 |
| AU5110896A (en) | 1996-10-02 |
| KR19980703058A (en) | 1998-09-05 |
| MX9707009A (en) | 1997-11-29 |
| IL117516A0 (en) | 1996-07-23 |
| IL117516A (en) | 2000-07-26 |
| JPH11501649A (en) | 1999-02-09 |
| HUP9801691A3 (en) | 1999-03-01 |
| CZ289697A3 (en) | 1997-12-17 |
| WO1996028165A1 (en) | 1996-09-19 |
| CA2215382A1 (en) | 1996-09-19 |
| AU713258B2 (en) | 1999-11-25 |
| NO974255D0 (en) | 1997-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2091069C1 (en) | Agent for hormonal contraception that inhibits ovulation | |
| RU2169566C2 (en) | Method and remedy for creating hormone contraception and/or treating acne | |
| CY1105276T1 (en) | TRIPHASIC ORAL CONTRACEPTIVE | |
| KR960704553A (en) | PREPARATION FOR SUBSTITUTION THERAPY CONTAINING AT LEAST ONE PROGESTOGEN AND AT LEAST ONE ESTROGEN | |
| NZ234051A (en) | Treating post-menopausal disorders using an estrogenic compound mixed with a compound having progestational activity | |
| AU645382B2 (en) | Low estrogen oral contraceptives | |
| SK178097A3 (en) | Pharmaceutical combined preparation, kit and method for hormonal contraception | |
| DK0491438T3 (en) | Pregnancy prevention treatment | |
| AU3436097A (en) | Progestogen-anti-progestogen regimens | |
| IL94416A (en) | Pharmaceutical compositions containing dihydrospirorenone | |
| PL327182A1 (en) | Method of preventing conception among female mammals through combined application of gestagen and oestrogen and combination of active agent therefor | |
| Ulmann | Uses of RU 486 for contragestion: an update | |
| WO1994002103A3 (en) | Ovulation inhibitor for hormonal contraception | |
| NO314437B1 (en) | Use of at least ± n competitive progesterone antagonist for the manufacture of a drug for need-oriented, female fertility control | |
| NO974255L (en) | Preparation for once-daily injection month and useful as a depot contraceptive and in hormone replacement therapy for perimenopausal and premenopausal women | |
| Sample | Pharmacology of contraceptive agents-new compounds with new problems? | |
| Wood | Hormonal contraception: current perspectives. Part I. An analysis of available agents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |